Brian Cahill - Jan 30, 2023 Form 4 Insider Report for EAGLE PHARMACEUTICALS, INC. (EGRX)

Role
Chief Financial Officer
Signature
/s/ Brian Cahill
Stock symbol
EGRX
Transactions as of
Jan 30, 2023
Transactions value $
-$19,959
Form type
4
Date filed
1/31/2023, 05:21 PM
Previous filing
Jan 9, 2023
Next filing
Feb 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EGRX Common Stock Tax liability -$20K -601 -1.91% $33.21 30.9K Jan 30, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The disposition reported on this Form 4 represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units.